When was Brainxell founded?

Brainxell was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is Brainxell located?

Brainxell is headquartered in Madison, United States.

How many employees does Brainxell have?

As of Apr 30, 2026, the latest employee count at Brainxell is 42.

Is Brainxell a funded company?

Brainxell is a funded company, having raised a total of $13.2M across 7 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Sep 01, 2016.

When was the latest funding round of Brainxell?

Brainxell's latest funding was a $***** Grant (prize money) round on Aug 17, 2023, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $640M in funding in 2026 to date.

Where does Brainxell rank among its competitors?

Brainxell ranks 166th amongst 2061 active competitors, of which 500 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of Brainxell?

Brainxell's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences. Among them, Antheia secured the most recent funding round in January, 2026.

Brainxell - 2026 Company Profile, Team, Funding & Competitors

Company Details

BrainXell develops neural stem cells and progenitor stem cells for life science research. Its platform technology has been developed by researchers at University of Wisconsin-Madison and enables the large scale production of neural progenitor and stem cells from induced pluripotent stem cells (iPSCs) or embryonic stem cells. The company claims that its process can produce up to two billion neurons. BrainXell's product line includes spinal cord motor neurons, midbrain dopaminergic neurons, glutamatergic neurons, GABAergic neurons and mixed cortical neurons, while striatal GABAergic neurons, serotonergic neurons, basal forebrain cholinergic neurons, and astrocytes are under development. The company licenses its iPSCs from iPS Japan.

Website: brainxell.com
Email ID: *****@brainxell.com

Key Metrics

Founded Year

2015

Location

Madison, United States

Stage

Series B

Total Funding

$13.2M in 7 rounds

Latest Funding Round

Grant (prize money), Aug 17, 2023, $*****

Investors

WARF & 2 more

Ranked

166^th among 2061 active competitors

Employee Count

42 as on Apr 30, 2026

Similar Companies

Sutro Biopharma & 2782 more

View Brainxell's full profile

Brainxell is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BRAINXELL, INC. CIN: 474451322 , United States, Active	Dec 31, 1999	-	45 (As on Dec 31, 2024)	-

Brainxell has raised a total funding of $13.2M over 7 rounds. Its first funding round was on Sep 01, 2016. Its latest funding round was a Grant (prize money) round on Aug 17, 2023 for $*****. 1 investor participated in its latest round. Brainxell has 3 institutional investors.

Here is the list of recent funding rounds of Brainxell:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 17, 2023	1275716	Grant (prize money)	1027998	8072093	5201988	5610370
Aug 27, 2021	1845737	Series B	9457885	7507798	8584505	4499341
May 01, 2021	9075970	Grant (prize money)	9543458	2632321	3621589	Military Health

Access funding benchmarks and valuations. Sign up today!

View details of Brainxell's funding rounds and investors

The founders of Brainxell is Su Chun Zhang.

Here are the details of Brainxell's key team members:

Su Chun Zhang: Founder of Brainxell.

View details of Brainxell's Founder profiles and Board Members

Brainxell's employee count trend

Brainxell has 42 employees as of Apr 26. Here is Brainxell's employee count trend over the years:

Uncover Brainxell's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Brainxell include Sutro Biopharma, Synthego and Avidity Biosciences. Here is the list of Top 10 competitors of Brainxell, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
2nd	Synthego 2012, Redwood City (United States), Acquired	Developer of CRISPR-engineered cell and gene therapies	$460M	8VC, RA Capital Management & 30 others	71/100
3rd	Avidity Biosciences 2012, San Diego (United States), Acquired	RNA therapeutics innovator targeting muscle and other diseases with AOC platform	$143M	RTW Investments, Takeda Ventures & 20 others	70/100
4th	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
5th	Ventyx Biosciences 2018, Encinitas (United States), Acquired	Developer of therapeutics to treat autoimmune diseases	$165M	VenBio, Logos Capital & 13 others	66/100
6th	Transcenta 2019, Suzhou (China), Public	Developer of antibody-based therapeutics	$205M	Lilly Asia Ventures, Temasek & 11 others	66/100
7th	Akeso 2012, Zhongshan (China), Public	Developer of antibody drug conjugates for the treatment of broad spectrum diseases	$195M	Orbimed, Sino Biopharmaceutical & 18 others	65/100
8th	Aspen Neuroscience 2018, San Diego (United States), Series C	Provider of genomic-based personalised pluripotent stem cell therapy	$339M	Orbimed, Revelation Partners & 22 others	65/100
9th	Cellino 2017, Cambridge (United States), Series A	Developer of autologous cell therapies	$125M	Khosla Ventures, Humboldt Fund & 7 others	65/100
10th	Korro Bio 2018, Cambridge (United States), Public	Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases	$4M	Fidelity Investments, Monashee Investment Management ... & 14 others	64/100
166th	Brainxell 2015, Madison (United States), Series B	Neural stem cells and progenitor cells for life science research	$13.2M	WARF, Military Health & 1 others	47/100